Evidence map›Paper›PMID 34007877›Full record

ArticleMedicina clinica (English ed.)2021

Point-of-care ultrasonography in the initial characterization of patients with COVID-19.

Yale Tung-Chen, Ana Algora-Martín, Rafael Llamas-Fuentes, Pablo Rodríguez-Fuertes, Ana María Martínez Virto, Elena Sanz-Rodríguez, Blanca Alonso-Martínez, Maria Angélica Rivera Núñez

Abstract read
In one paragraph

Article in Medicina clinica (English ed.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yale Tung-ChenDepartment of Internal Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Ana Algora-MartínDepartment of Emergency Medicine, Hospital Universitario La Paz, Madrid, Spain.
Rafael Llamas-FuentesDepartment of Emergency Medicine, Hospital Universitario Reina Sofía, Cordoba, Spain.
Pablo Rodríguez-FuertesDepartment of Emergency Medicine, Hospital Universitario La Paz, Madrid, Spain.
Ana María Martínez VirtoDepartment of Emergency Medicine, Hospital Universitario La Paz, Madrid, Spain.
Elena Sanz-RodríguezDepartment of Emergency Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.
Blanca Alonso-MartínezDepartment of Internal Medicine, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain.
Maria Angélica Rivera NúñezDepartment of Emergency Medicine, Hospital Universitario La Paz, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is growing evidence regarding the imaging findings of coronavirus disease 2019 (COVID-19) in chest X-rays and computed tomography scans; however, their availability during this pandemic outbreak might be compromised. Currently, the role of point-of-care ultrasonography (POCUS) has yet to be explored.

objectivesTo describe the POCUS findings of COVID-19 in patients with the disease admitted to the emergency department (ED), correlating them with vital signs, laboratory and radiologic results, therapeutic decisions, and the prognosis.

methodsProspective study performed in the ED of 2 academic hospitals. Patients with highly suspected or confirmed COVID-19 underwent a lung ultrasonography (lung POCUS), focused cardiac ultrasound (FOCUS), and inferior vena cava (IVC) exam.

resultsBetween March and April 2020, 96 patients were enrolled. The mean age was 68.2 years (SD 17.5). The most common findings in the lung POCUS were an irregular pleural line (63.2%), bilateral confluence (55.2%), and isolated B-lines (53.1%), which were associated with a positive RT-PCR (odds ratio 4.327; 95% CI 1.216-15.401;

conclusionsPOCUS parameters have the potential to impact the diagnosis, management, and prognosis of patients with confirmed or suspected COVID-19.

Indexed as

Coronavirus disease 2019 (COVID-19)Focused cardiac ultrasonography (FOCUS).Point-of-care ultrasonography (POCUS)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Identifiers

PMID34007877
PMCPMC8120770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.